Polyamine deprivation prevents the development of tumour-induced immune suppression

Br J Cancer. 1997;76(3):365-70. doi: 10.1038/bjc.1997.391.

Abstract

Mice grafted with the 3LL (Lewis lung) carcinoma exhibit immune suppression: spleen cells showed decreased spontaneous interleukin 2 (IL-2) production and T-CD4+ and T-CD8+ lymphocyte populations; in addition the polyamine content in the spleen was increased. By treating the mice with a polyamine-deficient diet containing neomycin, metronidazole and inhibitors of ornithine decarboxylase and polyamine oxydase, tumour growth was reduced and the immune abnormalities were reversed. The spleen cells overproduced IL-2 by reducing exogenous sources of polyamines, but total blockade of all major polyamine sources was necessary to obtain an optimal effect both on IL-2 production and on spleen polyamine content. Irrespective of whether polyamine deprivation was started at an early or at an advanced stage of tumour growth, T-lymphocyte populations were restored to normal values, demonstrating that polyamine deprivation not only prevents tumour-induced immune suppression, but reverses established immunological disorders. In contrast to what was observed regarding IL-2 production by spleen cells and natural killer (NK) cell activity, the polyamine oxidase (PAO) inhibitor did not enhance the number of T lymphocytes. These findings are consistent with a direct effect of the polyamines on immune effector cell metabolism. They suggest an important role of the gastrointestinal polyamines and of PAO activity in the regulation of IL-2 production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Lewis Lung / immunology*
  • Dinoprostone / blood
  • Eflornithine / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Immune Tolerance*
  • Interleukin-2 / biosynthesis*
  • Lymphocyte Activation
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Neoplasm Transplantation
  • Organ Size
  • Oxidoreductases Acting on CH-NH Group Donors / antagonists & inhibitors
  • Polyamine Oxidase
  • Polyamines / metabolism*
  • Putrescine / analogs & derivatives
  • Putrescine / pharmacology
  • Spleen / anatomy & histology
  • Spleen / cytology
  • T-Lymphocytes / cytology
  • T-Lymphocytes / immunology*

Substances

  • Enzyme Inhibitors
  • Interleukin-2
  • Polyamines
  • MDL 72527
  • Oxidoreductases Acting on CH-NH Group Donors
  • Dinoprostone
  • Putrescine
  • Eflornithine